Form D · Pharmaceuticals

HARROW HEALTH, INC.

Nashville, TN · CIK 0001360214

Offering snapshot reported May 14, 2021 · SEC filing

Reported sold
$10.7M
Offering amount: $10.7M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 5, 2021
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 14, 2021Initial$10,670,000No comparison1SEC filing
Dec 30, 2016Initial$10,068,740No comparison143SEC filing
Jan 15, 2015Initial$500,000No comparison2SEC filing
May 3, 2012Initial$7,946,180No comparison118SEC filing
May 15, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Oct 4, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Feb 27, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-399461

Source: Form D, filed May 14, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeffrey Abrams Director
Stephen Austin Director
Mark L Baum Executive
Andrew R Boll Executive
Balbir Brar Director, Executive
Paul Finnegan Director
Robert J Kammer Director
Richard L Lindstrom Director
William H. Nelson Director
Anthony Principi Director
Joachim Schupp Executive
Teresa F Sparks Director
R Larry Van Horn Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
102 Woodmont Blvd. Suite 610
Nashville, TN, 37205